WHO ICTRP trial
Phase I / II, Multicenter Clinical trial to evaluate the safe dose range and…
KCT0004770 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0004770 |
|---|---|
| Public title | Phase I / II, Multicenter Clinical trial to evaluate the safe dose range and confirm the effectiveness and safety of the maximum tolerated dose of Docetaxel In combination with SH003 in patients with solid tumor who are indicated for Docetaxel |
| Scientific title | Phase I / II, Multicenter Clinical trial to evaluate the safe dose range and confirm the effectiveness and safety of the maximum tolerated dose of Docetaxel In combination with SH003 in patients with solid tumor who are indicated for Docetaxel |
| Primary sponsor | Korea University Anam Hospital |
| Secondary sponsors | Ajou University Hospital |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Phase1/Phase2 |
| Countries | Korea, Republic of |
| Conditions | Neoplasms |
| Interventions | Drug : 1. Experimental Group Patients with histologically and cytologically confirmed lung or breast cancer with docetaxel indication 2. Starting dose, administration method and administration period 1) Starting dose - SH003 : 2 tablets at… |
| Registration date | Feb 26, 2020 |
| Target size | 110 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: